1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prostate Cancer Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Biological Therapy 1.2.3 Chemotherapy 1.3 Market by Application 1.3.1 Global Prostate Cancer Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Research Institution 1.3.4 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prostate Cancer Treatment Market Perspective (2017-2028) 2.2 Prostate Cancer Treatment Growth Trends by Region 2.2.1 Prostate Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Prostate Cancer Treatment Historic Market Size by Region (2017-2022) 2.2.3 Prostate Cancer Treatment Forecasted Market Size by Region (2023-2028) 2.3 Prostate Cancer Treatment Market Dynamics 2.3.1 Prostate Cancer Treatment Industry Trends 2.3.2 Prostate Cancer Treatment Market Drivers 2.3.3 Prostate Cancer Treatment Market Challenges 2.3.4 Prostate Cancer Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prostate Cancer Treatment Players by Revenue 3.1.1 Global Top Prostate Cancer Treatment Players by Revenue (2017-2022) 3.1.2 Global Prostate Cancer Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Prostate Cancer Treatment Revenue 3.4 Global Prostate Cancer Treatment Market Concentration Ratio 3.4.1 Global Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Treatment Revenue in 2021 3.5 Prostate Cancer Treatment Key Players Head office and Area Served 3.6 Key Players Prostate Cancer Treatment Product Solution and Service 3.7 Date of Enter into Prostate Cancer Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prostate Cancer Treatment Breakdown Data by Type 4.1 Global Prostate Cancer Treatment Historic Market Size by Type (2017-2022) 4.2 Global Prostate Cancer Treatment Forecasted Market Size by Type (2023-2028) 5 Prostate Cancer Treatment Breakdown Data by Application 5.1 Global Prostate Cancer Treatment Historic Market Size by Application (2017-2022) 5.2 Global Prostate Cancer Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Prostate Cancer Treatment Market Size (2017-2028) 6.2 North America Prostate Cancer Treatment Market Size by Country (2017-2022) 6.3 North America Prostate Cancer Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Prostate Cancer Treatment Market Size (2017-2028) 7.2 Europe Prostate Cancer Treatment Market Size by Country (2017-2022) 7.3 Europe Prostate Cancer Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Prostate Cancer Treatment Market Size (2017-2028) 8.2 Asia-Pacific Prostate Cancer Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Prostate Cancer Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Prostate Cancer Treatment Market Size (2017-2028) 9.2 Latin America Prostate Cancer Treatment Market Size by Country (2017-2022) 9.3 Latin America Prostate Cancer Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prostate Cancer Treatment Market Size (2017-2028) 10.2 Middle East & Africa Prostate Cancer Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Prostate Cancer Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Tolmar 11.1.1 Tolmar Company Detail 11.1.2 Tolmar Business Overview 11.1.3 Tolmar Prostate Cancer Treatment Introduction 11.1.4 Tolmar Revenue in Prostate Cancer Treatment Business (2017-2022) 11.1.5 Tolmar Recent Development 11.2 Astellas Pharma 11.2.1 Astellas Pharma Company Detail 11.2.2 Astellas Pharma Business Overview 11.2.3 Astellas Pharma Prostate Cancer Treatment Introduction 11.2.4 Astellas Pharma Revenue in Prostate Cancer Treatment Business (2017-2022) 11.2.5 Astellas Pharma Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Detail 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Prostate Cancer Treatment Introduction 11.3.4 AstraZeneca Revenue in Prostate Cancer Treatment Business (2017-2022) 11.3.5 AstraZeneca Recent Development 11.4 Ferring Pharmaceuticals 11.4.1 Ferring Pharmaceuticals Company Detail 11.4.2 Ferring Pharmaceuticals Business Overview 11.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Introduction 11.4.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2017-2022) 11.4.5 Ferring Pharmaceuticals Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Detail 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Prostate Cancer Treatment Introduction 11.5.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2017-2022) 11.5.5 Johnson & Johnson Recent Development 11.6 Abbott 11.6.1 Abbott Company Detail 11.6.2 Abbott Business Overview 11.6.3 Abbott Prostate Cancer Treatment Introduction 11.6.4 Abbott Revenue in Prostate Cancer Treatment Business (2017-2022) 11.6.5 Abbott Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Detail 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Prostate Cancer Treatment Introduction 11.7.4 Sanofi Revenue in Prostate Cancer Treatment Business (2017-2022) 11.7.5 Sanofi Recent Development 11.8 Ipsen 11.8.1 Ipsen Company Detail 11.8.2 Ipsen Business Overview 11.8.3 Ipsen Prostate Cancer Treatment Introduction 11.8.4 Ipsen Revenue in Prostate Cancer Treatment Business (2017-2022) 11.8.5 Ipsen Recent Development 11.9 Novartis 11.9.1 Novartis Company Detail 11.9.2 Novartis Business Overview 11.9.3 Novartis Prostate Cancer Treatment Introduction 11.9.4 Novartis Revenue in Prostate Cancer Treatment Business (2017-2022) 11.9.5 Novartis Recent Development 11.10 Bayer 11.10.1 Bayer Company Detail 11.10.2 Bayer Business Overview 11.10.3 Bayer Prostate Cancer Treatment Introduction 11.10.4 Bayer Revenue in Prostate Cancer Treatment Business (2017-2022) 11.10.5 Bayer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Biological Therapy Table 3. Key Players of Chemotherapy Table 4. Global Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Prostate Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Prostate Cancer Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Prostate Cancer Treatment Market Share by Region (2017-2022) Table 8. Global Prostate Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Prostate Cancer Treatment Market Share by Region (2023-2028) Table 10. Prostate Cancer Treatment Market Trends Table 11. Prostate Cancer Treatment Market Drivers Table 12. Prostate Cancer Treatment Market Challenges Table 13. Prostate Cancer Treatment Market Restraints Table 14. Global Prostate Cancer Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Prostate Cancer Treatment Market Share by Players (2017-2022) Table 16. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment as of 2021) Table 17. Ranking of Global Top Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Prostate Cancer Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Prostate Cancer Treatment Product Solution and Service Table 21. Date of Enter into Prostate Cancer Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Prostate Cancer Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Prostate Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Prostate Cancer Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Prostate Cancer Treatment Revenue Market Share by Application (2017-2022) Table 29. Global Prostate Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Prostate Cancer Treatment Revenue Market Share by Application (2023-2028) Table 31. North America Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Prostate Cancer Treatment Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Prostate Cancer Treatment Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Tolmar Company Detail Table 42. Tolmar Business Overview Table 43. Tolmar Prostate Cancer Treatment Product Table 44. Tolmar Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 45. Tolmar Recent Development Table 46. Astellas Pharma Company Detail Table 47. Astellas Pharma Business Overview Table 48. Astellas Pharma Prostate Cancer Treatment Product Table 49. Astellas Pharma Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 50. Astellas Pharma Recent Development Table 51. AstraZeneca Company Detail Table 52. AstraZeneca Business Overview Table 53. AstraZeneca Prostate Cancer Treatment Product Table 54. AstraZeneca Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 55. AstraZeneca Recent Development Table 56. Ferring Pharmaceuticals Company Detail Table 57. Ferring Pharmaceuticals Business Overview Table 58. Ferring Pharmaceuticals Prostate Cancer Treatment Product Table 59. Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 60. Ferring Pharmaceuticals Recent Development Table 61. Johnson & Johnson Company Detail Table 62. Johnson & Johnson Business Overview Table 63. Johnson & Johnson Prostate Cancer Treatment Product Table 64. Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 65. Johnson & Johnson Recent Development Table 66. Abbott Company Detail Table 67. Abbott Business Overview Table 68. Abbott Prostate Cancer Treatment Product Table 69. Abbott Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 70. Abbott Recent Development Table 71. Sanofi Company Detail Table 72. Sanofi Business Overview Table 73. Sanofi Prostate Cancer Treatment Product Table 74. Sanofi Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 75. Sanofi Recent Development Table 76. Ipsen Company Detail Table 77. Ipsen Business Overview Table 78. Ipsen Prostate Cancer Treatment Product Table 79. Ipsen Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 80. Ipsen Recent Development Table 81. Novartis Company Detail Table 82. Novartis Business Overview Table 83. Novartis Prostate Cancer Treatment Product Table 84. Novartis Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 85. Novartis Recent Development Table 86. Bayer Company Detail Table 87. Bayer Business Overview Table 88. Bayer Prostate Cancer Treatment Product Table 89. Bayer Revenue in Prostate Cancer Treatment Business (2017-2022) & (US$ Million) Table 90. Bayer Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate Cancer Treatment Market Share by Type: 2021 VS 2028 Figure 2. Biological Therapy Features Figure 3. Chemotherapy Features Figure 4. Global Prostate Cancer Treatment Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Research Institution Case Studies Figure 7. Clinic Case Studies Figure 8. Prostate Cancer Treatment Report Years Considered Figure 9. Global Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Prostate Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Prostate Cancer Treatment Market Share by Region: 2021 VS 2028 Figure 12. Global Prostate Cancer Treatment Market Share by Players in 2021 Figure 13. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Revenue in 2021 Figure 15. North America Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Prostate Cancer Treatment Market Share by Country (2017-2028) Figure 17. United States Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Prostate Cancer Treatment Market Share by Country (2017-2028) Figure 21. Germany Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Prostate Cancer Treatment Market Share by Region (2017-2028) Figure 29. China Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Prostate Cancer Treatment Market Share by Country (2017-2028) Figure 37. Mexico Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Prostate Cancer Treatment Market Share by Country (2017-2028) Figure 41. Turkey Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Tolmar Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 44. Astellas Pharma Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 45. AstraZeneca Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 46. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 47. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 48. Abbott Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 49. Sanofi Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 50. Ipsen Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 51. Novartis Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 52. Bayer Revenue Growth Rate in Prostate Cancer Treatment Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Tolmar Astellas Pharma AstraZeneca Ferring Pharmaceuticals Johnson & Johnson Abbott Sanofi Ipsen Novartis Bayer